• SENSEX
    NIFTY 50
Business

Dapagliflozin shows significant benefits in patients with chronic kidney disease: AstraZeneca

Updated : August 31, 2020 04:14 PM IST

Dapagliflozin shows significant benefits in patients with chronic kidney disease: AstraZeneca

You May Also Like

Live TV

recommended for you

Advertisement